1.0 NAPNAP contact hour of which 0.25 contain pharmacology content. This continuing education activity is offered FREE to Members and Nonmembers.

The purpose of this program is to inform primary care pediatric health care providers about the management of children and adolescents with obesity guided by the American Academy of Pediatrics (AAP) Clinical Practice Guidelines published in 2023. The presentation content focuses on how to implement best practices for the management of children and adolescents with obesity including pharmacotherapy. Additionally, guidance on the AAP resources and how to access and utilize these tools will be discussed. 

IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP.  If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: ce@napnap.org 

Copyright 2023 © by the NAPNAP Childhood Obesity SIG

This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 1.0 NAPNAP contact hour, of which 0.25 contain pharmacology content

Keywords: Obesity Medications, Obesity Treatment